According to the National Cancer Institute

According to the National Cancer Institute, lung cancer is the second most common cancer and primary cause of cancer-related death in both men and women in the United States. The overall death rate for lung and bronchus cancers rose steadily through the 1980s, peaked in the early 1990s, and has been slowly declining since 2001. Trends in lung cancer incidence and death rates have closely mirrored historical patterns of smoking prevalence, after accounting for a gap period. Because the prevalence of smoking peaked later in women than in men, lung cancer incidence and death rates began declining later for women than men. The incidence rate has been declining since the mid-1980s in men but only since the mid-2000s in women; the mortality rate began declining in 1991 in men and but not until 2003 in women. Incidence and mortality rates are highest among African American men, followed by white men.
Although smoking is the main cause of lung cancer, lung cancer risk also is increased by exposure to secondhand smoke, environmental exposures, such as radon, workplace toxins (e.g., asbestos, arsenic), and air pollution. The risk of lung cancer can be reduced by quitting smoking and by eliminating or reducing exposure to secondhand smoke and environmental and workplace risk factors. The National Lung Screening Trial has shown that screening current or former heavy smokers with low-dose helical computed tomography (CT) decreases their risk of dying from lung cancer. Standard treatments for lung cancer include surgery, radiation therapy, chemotherapy, targeted therapy, laser therapy, photodynamic therapy, cryosurgery, endoscopic stent placement, and electro cautery.